世界中医药2024,Vol.19Issue(16) :2484-2488.DOI:10.3969/j.issn.1673-7202.2024.16.019

高彦彬教授从络病论治慢性肾衰经验

Professor GAO Yanbin's Experience in Treating Chronic Renal Failure from Collateral Diseases

刘甜甜 高彦彬 王莺洁 邢俊艳 崔家霖 朱智耀 邹大威
世界中医药2024,Vol.19Issue(16) :2484-2488.DOI:10.3969/j.issn.1673-7202.2024.16.019

高彦彬教授从络病论治慢性肾衰经验

Professor GAO Yanbin's Experience in Treating Chronic Renal Failure from Collateral Diseases

刘甜甜 1高彦彬 2王莺洁 1邢俊艳 1崔家霖 1朱智耀 2邹大威2
扫码查看

作者信息

  • 1. 首都医科大学中医药学院,北京,100069
  • 2. 首都医科大学中医药学院,北京,100069;高彦彬全国名老中医药专家传承工作室,北京,100069;中医络病研究北京重点实验室,北京,100069
  • 折叠

摘要

慢性肾衰是各类进展性肾脏疾病的最终结局,病机错综复杂,中医对其治疗具有较好疗效.高彦彬教授学术思想师承国医大师吕仁和教授,临证四十载,认为此病属于"络病"范畴,并针对慢性肾衰提出肾元虚衰、肾络瘀结、浊毒内停的基本病机和益气固肾、解毒通络的基本治法.临床上以虚定型,以实定候进行辨证论治,并基于治未病理论,提出慢性肾病三级预防策略.

Abstract

Chronic renal failure is the ultimate outcome of various progressive kidney diseases,characterized by complex pathogen-esis.Traditional Chinese medicine(TCM)has shown significant efficacy in its treatment.Professor GAO Yanbin,whose academic philosophy follows the teachings of Master Physician Lv Renhe,has over 40 years of clinical experience.He believes that this condi-tion falls within the category of collateral diseases.For chronic renal failure,he proposes the fundamental pathogenesis of kidney es-sence deficiency,stagnation of kidney collaterals,and internal retention of turbid toxins,as well as basic therapeutic approaches in-volving tonifying qi and consolidating the kidneys,removing toxins,and dredging the collaterals.In clinical practice,syndrome dif-ferentiation and treatment are based on defining the condition as primarily deficient with secondary excess manifestations.Addition-ally,adhering to the theory of preventive treatment,Professor GAO has proposed a three-level prevention strategy for chronic kidney disease.

关键词

慢性肾衰/络病/中医药/辨证论治/病因病机/名老中医/名医经验/@高彦彬

Key words

Chronic renal failure/Collateral disease/Traditional Chinese medicine/Syndrome differentiation and treatment/Eti-ology and pathogenesis/Famous veteran TCM doctor/Experience of famous doctor/@GAO Yanbin

引用本文复制引用

基金项目

国家重点基础研究发展计划(973计划)项目(2018YFC1704102)

出版年

2024
世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
段落导航相关论文